摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-二氢-1,4-苯并二恶烷-5-羰酰氯 | 38871-41-9

中文名称
2,3-二氢-1,4-苯并二恶烷-5-羰酰氯
中文别名
苯并二氧六环-5-甲酰氯;2,3-二氢-1,4-苯并二噁英-5-羰酰氯;1,4-苯并二烷-5-甲酰氯
英文名称
1,4-benzodioxan-5-carbonyl chloride
英文别名
1,4-benzodioxan-5-carboxylic acid chloride;2,3-dihydrobenzo[b][1,4]dioxine-5-carbonyl chloride;2,3-dihydro-benzo[1,4]dioxin-5-carbonyl chloride;1,4-benzodioxane-5-carbonyl chloride;2,3-ETHYLENEDIOXYBENZOYL CHLORIDE;2,3-Dihydro-1,4-benzodioxine-5-carbonyl chloride
2,3-二氢-1,4-苯并二恶烷-5-羰酰氯化学式
CAS
38871-41-9
化学式
C9H7ClO3
mdl
——
分子量
198.606
InChiKey
IEWVBBWTJOHHCY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    98 °C
  • 密度:
    1.371

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    C
  • 危险类别码:
    R34
  • 危险品运输编号:
    UN 3261
  • 安全说明:
    S26,S36/37/39,S45
  • 包装等级:
    III
  • 危险类别:
    8
  • 危险性防范说明:
    P280,P305+P351+P338,P310
  • 危险性描述:
    H314
  • 储存条件:
    2-8°C

SDS

SDS:809974ce810fd63b93388b3073ab61b0
查看
Name: 2 3-Dihydro-1 4-benzodioxine-5-carbonyl chloride 97% Material Safety Data Sheet
Synonym:
CAS: 38871-41-9
Section 1 - Chemical Product MSDS Name:2 3-Dihydro-1 4-benzodioxine-5-carbonyl chloride 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
38871-41-9 2,3-Dihydro-1,4-benzodioxine-5-carbony 97% unlisted
Hazard Symbols: C
Risk Phrases: 34

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.Moisture sensitive.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area. Store under an inert atmosphere.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 38871-41-9: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 77.3 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H7ClO3
Molecular Weight: 198.6

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, exposure to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 38871-41-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2,3-Dihydro-1,4-benzodioxine-5-carbonyl chloride - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.*
Hazard Class: 8
UN Number: 3261
Packing Group: III
IMO
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 38871-41-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 38871-41-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 38871-41-9 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity
    摘要:
    A series of 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety (3a-3r) has been designed, synthesized and their biological activities were also evaluated as potential antiproliferation and focal adhesion kinase (FAK) inhibitors. Among all the compounds, 3p showed the most potent activity in vitro which inhibited the growth of A549 with IC50 value of 3.11 mu M and Hela with IC50 value of 2.54 mu M respectively. Compound 3p also exhibited significant FAK inhibitory activity (IC50 = 0.45 mu M). Docking simulation was performed for compound 3p into the FAK structure active site to determine the probable binding model. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2014.04.005
  • 作为产物:
    参考文献:
    名称:
    REPLACEMENT OF NUCLEAR ALKOXYL GROUPS BY THE ACTION OF GRIGNARD REAGENTS
    摘要:
    DOI:
    10.1021/jo01162a005
点击查看最新优质反应信息

文献信息

  • Compounds of N-benzoylpyroline
    申请人:Adir et Compagnie
    公开号:US05332735A1
    公开(公告)日:1994-07-26
    Compounds of the general formula (I): ##STR1## where A, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are defined in the description. Medicinal products.
    通式(I)的化合物:##STR1## 其中A,R.sub.1,R.sub.2,R.sub.3,R.sub.4,R.sub.5和R.sub.6在描述中有定义。药用产品。
  • Cobalt-Catalyzed C(sp<sup>2</sup>)−H Methylation by using Dicumyl Peroxide as both the Methylating Reagent and Hydrogen Acceptor
    作者:Qun Li、Yanrong Li、Weipeng Hu、Renjian Hu、Guigen Li、Hongjian Lu
    DOI:10.1002/chem.201602445
    日期:2016.8.22
    The first cobalt‐catalyzed direct methylation of a C(sp2)−H bond using dicumyl peroxide (DCP) as both the methylating reagent and hydrogen acceptor has been established. The reaction proceeded without the use of any additives, and was proven to be applicable to various amides bearing a 2‐pyridinylisopropyl (PIP) directing group, providing an efficient access to o‐methyl aryl amides with high functional‐group
    已经建立了使用过氧化二枯基(DCP)作为甲基化试剂和氢受体的第一个催化的C(sp 2)-H键的直接甲基化反应。该反应无需使用任何添加剂即可进行,并且已证明可用于带有2-吡啶基异丙基(PIP)导向基团的各种酰胺,从而可以高效地获得具有高官能团耐受性的邻甲基芳基酰胺。初步的机理研究表明,催化过程将涉及自由基过程。
  • Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method
    申请人:Societe D'Etudes Scientifiques et Industrielles de L'ile-de-France
    公开号:US04186135A1
    公开(公告)日:1980-01-29
    Novel substituted 2,3-alkylene bis (oxy) benzamides and derivatives thereof are disclosed. Also disclosed is a method for producing said compounds. The compounds have anxiolytic, psychostimulant, disinhibiting and thymoanaleptic properties useful therapeutically in the psychofunctional field, particularly in gastro-enterology, cardiology, urology, rheumatology and gynaecology.
    揭示了新型取代的2,3-烷基双(氧基)苯甲酰胺及其衍生物。还公开了一种生产该类化合物的方法。这些化合物具有抗焦虑、精神刺激、解禁和抗抑郁特性,在心理功能领域中具有治疗作用,特别是在胃肠病学、心脏病学、泌尿学、风湿病学和妇科学中。
  • Palladium-Catalyzed Electrochemical C–H Bromination Using NH<sub>4</sub>Br as the Brominating Reagent
    作者:Qi-Liang Yang、Xiang-Yang Wang、Tong-Lin Wang、Xiang Yang、Dong Liu、Xiaofeng Tong、Xin-Yan Wu、Tian-Sheng Mei
    DOI:10.1021/acs.orglett.9b00629
    日期:2019.4.19
    palladium-catalyzed electrochemical C–H bromination of benzamide derivatives under divided cells is developed, in which NH4Br serves as a brominating reagent and electrolyte. The protocol avoids the use of chemical oxidants and provides an alternative method for the synthesis of aryl bromides.
    在分裂的电池下,开发了催化的苯甲酰胺衍生物的电化学C–H化反应,其中NH 4 Br用作化试剂和电解质。该方案避免了使用化学氧化剂,并提供了另一种合成芳基化物的方法。
  • Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors
    作者:Dong-Dong Li、Fei Fang、Jing-Ran Li、Qian-Ru Du、Jian Sun、Hai-Bin Gong、Hai-Liang Zhu
    DOI:10.1016/j.bmcl.2012.07.079
    日期:2012.9
    It had been reported that some dioxygenated rings fusing with the quinazoline scaffold could lead to new EGFR inhibitors. Based on this, several kinds of oxygenated alkane quinazoline derivatives were synthetized and evaluated as EGFR inhibitors. Their antiproliferative activities were tested against four cancer cell lines: A431, MCF-7, A549, and B16-F10. Most derivatives could counteract EGF-induced
    据报道,一些与喹唑啉支架融合的双加氧环可能会导致新的EGFR抑制剂。基于此,合成了几种氧化的烷烃喹唑啉生物,并评价其为EGFR抑制剂。测试了它们对四种癌细胞系的抗增殖活性:A431,MCF-7,A549和B16-F10。大多数衍生物可以抵消EGF诱导的EGFR磷酸化,其效价与参考化合物厄洛替尼相当。稠合的双加氧环的大小对于生物活性至关重要,并且七原子环衍生物19在酶促测定和细胞测定中均显示出强大的体外抑制活性。
查看更多

同类化合物

顺式-6-氯-4-甲基-4-苯基-4H-1,3-苯并二氧杂环己-2-羧酸 阿莫齐特 苯并二氧六环-6-甲酸甲酯 苯并二氧六环-6-甲酰胺 苯并二氧六环-5-甲酸甲酯 苯并二氧六环-5-甲酰胺 苯并二氧六环-2-磺酰氯 苯并-1,4-二氧六环-6-硼酸 艾泽罗西 脲,N-(4-甲基-1-哌嗪基)- 胍苯克生 胍美柳 胍生 羧基-6-苯并(4H)二恶英-1,3 美商陆酚A 维兰特罗杂质4 硫酸(2:1)(1,4-苯并二噁烷-6-基甲基)胍正离子 盐酸艾美洛沙 盐酸哌罗克生 盐酸[(7-溴-2,3-二氢-1,4-苯并二恶英-6-基)甲基]肼 甲基氨基甲酸1,4-苯并二恶烷-5-基酯 甲基8-甲基-2,3-二氢-1,4-苯并二氧杂环己烷-6-羧酸酯 甲基7-甲基-2,3-二氢-1,4-苯并二氧杂环己烷-5-羧酸酯 甲基4-[(1E)-3-乙基-3-(羟甲基)三氮杂-1-烯-1-基]苯酸酯 甲基-[2-[(7-丙-2-烯基-2,3-二氢-1,4-苯并二氧杂环己-8-基)氧基]乙基]氯化铵 甲基(2S,4R)-6-氯-4-甲基-4-(2-噻吩基)-4H-1,3-苯并二氧杂环己烷-2-羧酸酯 溴(2,3-二氢-1,4-苯并二氧杂环己-6-基)镁 沙丁胺醇缩丙酮 异美商陆素 A 异戊苯恶烷 度莫辛 布他莫生 安必罗山 地奥地洛 噻唑并[5,4-b]吡啶-2-胺,N-[[1-[(2,3-二氢-1,4-苯并二噁英-2-基)甲基]-4-哌啶基]甲基]- 哌扑罗生 咪洛克生 咪唑克生盐酸盐 吡啶-3-磺酰氯盐酸盐 叔丁基 (2,3-二氢苯并[b][1,4]二噁英-6-基)氨基甲酸酯 反式-2,3-二氢-N-((4-(2-苯氧基乙基)-1-哌嗪基)甲基)-1,4-苯并二氧六环-2-甲酰胺 双恶哌嗪 冰达卡醇 依利格鲁司特酒石酸盐 依利格鲁司特杂质 依利格鲁司特中间体5 依利格鲁司特 亚达唑散 二氨基亚甲基-(2,3-二氢-1,4-苯并二氧杂环己-2-基甲基)铵硫酸盐 二-(叔丁基)2-(2,2-二甲基-4H-1,3-苯并二恶英-6-基)-2-氧代乙基亚氨基二碳酸